| Literature DB >> 31932454 |
Marwa Asem1,2,3, Allison M Young3, Carlysa Oyama3, Alejandro Claure De La Zerda3, Yueying Liu2,3, Jing Yang2,3, Tyvette S Hilliard2,3, Jeffery Johnson2,3, Elizabeth I Harper2,3, Ian Guldner3,4, Siyuan Zhang3,4, Toni Page-Mayberry3, William J Kaliney3, M Sharon Stack5,2,3.
Abstract
The noncanonical Wnt ligand Wnt5a is found in high concentrations in ascites of women with ovarian cancer. In this study, we elucidated the role of Wnt5a in ovarian cancer metastasis. Wnt5a promoted ovarian tumor cell adhesion to peritoneal mesothelial cells as well as migration and invasion, leading to colonization of peritoneal explants. Host components of the ovarian tumor microenvironment, notably peritoneal mesothelial cells and visceral adipose, secreted Wnt5a. Conditional knockout of host WNT5A significantly reduced peritoneal metastatic tumor burden. Tumors formed in WNT5A knockout mice had elevated cytotoxic T cells, increased M1 macrophages, and decreased M2 macrophages, indicating that host Wnt5a promotes an immunosuppressive microenvironment. The Src family kinase Fgr was identified as a downstream effector of Wnt5a. These results highlight a previously unreported role for host-expressed Wnt5a in ovarian cancer metastasis and suggest Fgr as a novel target for inhibition of ovarian cancer metastatic progression.Significance: This study establishes host-derived Wnt5a, expressed by peritoneal mesothelial cells and adipocytes, as a primary regulator of ovarian cancer intraperitoneal metastatic dissemination and identifies Fgr kinase as novel target for inhibition of metastasis. ©2020 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31932454 PMCID: PMC8245162 DOI: 10.1158/0008-5472.CAN-19-1601
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701